Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2007
Cellular cofactors affecting hepatitis C virus infection and replication
Glenn Randall, Maryline Panis, Jacob D Cooper, et al.
Nature Biotechnology
|
October 10, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Nature Communications
|
February 3, 2021
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Jerzy Osipiuk, Saara-Anne Azizi, Steve Dvorkin, et al.
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
Long Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Hepatology (Baltimore, Md.)
|
August 8, 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
Paula M Perin, Sibylle Haid, Richard J P Brown, et al.
Biorxiv : the Preprint Server for Biology
|
July 13, 2022
SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cells
Long C Nguyen, David M Renner, Diane Silva, et al.
Mbio
|
September 20, 2022
SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells
Long C Nguyen, David M Renner, Diane Silva, et al.
Biomaterials
|
May 19, 2026
Corrigendum to 'Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant' [Biomaterials, 128 (2021), 121159]
Laura T Gray, Michal M Raczy, Priscilla S Briquez, et al.
Biomaterials
|
October 11, 2021
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
Laura T Gray, Michal M Raczy, Priscilla S Briquez, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>
Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2007
Cellular cofactors affecting hepatitis C virus infection and replication
Glenn Randall, Maryline Panis, Jacob D Cooper, et al.
Nature Biotechnology
|
October 10, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Nature Communications
|
February 3, 2021
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Jerzy Osipiuk, Saara-Anne Azizi, Steve Dvorkin, et al.
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
Long Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Hepatology (Baltimore, Md.)
|
August 8, 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
Paula M Perin, Sibylle Haid, Richard J P Brown, et al.
Biorxiv : the Preprint Server for Biology
|
July 13, 2022
SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cells
Long C Nguyen, David M Renner, Diane Silva, et al.
Mbio
|
September 20, 2022
SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells
Long C Nguyen, David M Renner, Diane Silva, et al.
Biomaterials
|
May 19, 2026
Corrigendum to 'Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant' [Biomaterials, 128 (2021), 121159]
Laura T Gray, Michal M Raczy, Priscilla S Briquez, et al.
Biomaterials
|
October 11, 2021
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
Laura T Gray, Michal M Raczy, Priscilla S Briquez, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>
Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Page
of 8